Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

The global Endometriosis Therapies market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Therapies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis Therapies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endometriosis Therapies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists 
Progestin Therapy
Aromatase Inhibitors

Segment by Application
Hospital
Clinic
Other